Back to competency map

Clinical competency

Support patients with moderate-to-severe major depressive disorder

Therapists/facilitators require knowledge of treating patients with moderate-to-severe major depressive disorder in the context of psychedelic-assisted therapy. The target population in the trial establishes disorder-specific clinical knowledge needs.

Primary clinical guidelineModern clinical

Looking for something specific? Ask Blossom

Guidelines

2

Courses

0

Providers

0

Protocols

2

Classification

Care stages

Cross-phase

Protocol families

DMT / AyahuascaLSD

Source quality

Protocol paperTrial supplement

Linked sources

The guidelines, courses, and providers that evidence this competency. Full lists are a Blossom Pro feature.

Linked guidelines (2)

  • Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

    DMT / AyahuascaEvidence score: 100
    de Almeida et al., 2015Source PDF

Unlock every linked source

See all linked guidelines, courses, and providers behind this competency, plus the full competency graph.

Unlock full depth